A Netherton syndrome case report: Response to dupilumab treatment
Dermatol Ther
.
2022 Nov;35(11):e15862.
doi: 10.1111/dth.15862.
Epub 2022 Oct 6.
Authors
Giovanna Galdo
1
,
Luca Fania
2
Affiliations
1
Dermatology Unit, AORN San Giuseppe Moscati, Avellino, Italy.
2
Department of Dermatology, IDI IRCCS, Rome, Italy.
PMID:
36175157
DOI:
10.1111/dth.15862
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Netherton Syndrome* / diagnosis
Netherton Syndrome* / drug therapy
Substances
dupilumab
Antibodies, Monoclonal, Humanized